Development and Application of a Dynamic Three-dimensional Quantitative Facial Measurement Device

NCT ID: NCT05981651

Last Updated: 2023-08-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-01

Study Completion Date

2024-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this project is to successfully develop and industrialise the "Facial Movement 3D Dynamic Quantitative Measurement Device", which is a commercial device that can provide dynamic indicators of facial movement, and can practically solve the evaluation problems of facial paralysis for doctors and patients, and has important clinical value and social benefits.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Based on the current optimal high-precision face key point technology, the effective high-precision automatic face recognition model conforming to the Asian face is established through specialised training with targeted marker data, time series training optimisation based on optical flow, and local image tracking technology. The 3D reconstruction technique is then used to reconstruct the 3D spatial coordinates of the face keypoints, so as to realise the multi-camera 3D tracking of the face keypoints. The displacement of the key points is used to respond to the facial muscle activity characteristics of facial paralysis patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Facial Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

training session

A total of 150 facial expression videos of healthy volunteers and facial palsy patients were collected as a training set for the algorithm

non-intervention

Intervention Type OTHER

non-intervention

test set

A total of 50 cases of healthy volunteers and patients with facial palsy were used as the test set for the algorithm

non-intervention

Intervention Type OTHER

non-intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

non-intervention

non-intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Older than 14 years
2. No history of facial surgery, facial trauma, or scars obscuring the facial features.
3. Able to perform relevant actions according to instructions
4. Willingness to participate in the study

Exclusion Criteria

1. Unwillingness to participate in the study
2. Unable to co-operate with relevant command actions
3. Obvious trauma, scars, etc. obscuring the facial features
4. Less than 14 years of age
Minimum Eligible Age

14 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking Union Medical College Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Guodong Feng

chief physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guodong Feng

Role: PRINCIPAL_INVESTIGATOR

Peking Union Medical College Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Guodong Feng

Role: CONTACT

15001275266 ext. 010

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Guodong Feng

Role: primary

15001275266 ext. 010

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PekingUMCH record I-22PJ1121

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.